Skip to Main Content

For further information, see CMDT Part 22-17: Minimal Change Disease

Key Features

  • Nephrotic range proteinuria

  • In children, most common cause of proteinuric renal disease (80%)

  • In adults, accounts for 20–25% of cases of primary nephrotic syndrome in those over age 40 years

  • Can be idiopathic

  • May also occur

    • Following viral upper respiratory infections (especially in children)

    • In association with neoplasms, such as Hodgkin disease

    • With drugs (lithium)

    • With hypersensitivity reactions (especially to nonsteroidal anti-inflammatory drugs and bee stings)

Clinical Findings

  • Nephrotic syndrome

  • Can cause AKI due to renal tubular damage and interstitial edema

Diagnosis

  • No helpful serologic testing

  • Biopsy should be considered for children

    • With nephrotic syndrome who exhibit unusual features (such as signs of other systemic illness)

    • Who are corticosteroid-resistant

    • Who relapse upon withdrawal of corticosteroid therapy

  • Kidney biopsy

    • Light microscopy and immunofluorescence: no changes

    • Electron microscopy: characteristic effacement of podocyte foot processes

Treatment

  • Prednisone, 60 mg/m2/day orally

    • Remission generally occurs with 4–8 weeks

    • Can take up to 16 weeks for adult patient to respond to treatment

    • Continue for several weeks after complete remission of proteinuria

    • Dosing tapers should be individualized

    • Many patients relapse and require repeated corticosteroid treatment

  • Cyclophosphamide, a calcineurin inhibitor (tacrolimus, cyclosporine), or rituximab for patients with corticosteroid resistance or relapses

  • Progression to end-stage kidney disease is rare

  • Complications most often related to prolonged corticosteroid use

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.